EE04113B1 - Asendatud isokinoliinid kui ülilühikese toimekestusega perifeersed müorelaksandid ja nende valmistamine - Google Patents

Asendatud isokinoliinid kui ülilühikese toimekestusega perifeersed müorelaksandid ja nende valmistamine

Info

Publication number
EE04113B1
EE04113B1 EEP199900424A EEP9900424A EE04113B1 EE 04113 B1 EE04113 B1 EE 04113B1 EE P199900424 A EEP199900424 A EE P199900424A EE P9900424 A EEP9900424 A EE P9900424A EE 04113 B1 EE04113 B1 EE 04113B1
Authority
EE
Estonia
Prior art keywords
ultra
preparation
muscle relaxants
short acting
peripheral muscle
Prior art date
Application number
EEP199900424A
Other languages
English (en)
Estonian (et)
Inventor
Evan Boswell Grady
Anthony Mook Robert Jr.
Cleveland Bigham Eric
Joseph Savarese John
Archibald Swaringen Roy Jr.
Shashikant Patel Sanjay
Eugene Boros Eric
Samano Vincente
Original Assignee
Glaxo Group Limited
Cornell Research Foundation Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Glaxo Group Limited, Cornell Research Foundation Inc. filed Critical Glaxo Group Limited
Publication of EE9900424A publication Critical patent/EE9900424A/xx
Publication of EE04113B1 publication Critical patent/EE04113B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP199900424A 1997-03-25 1998-03-23 Asendatud isokinoliinid kui ülilühikese toimekestusega perifeersed müorelaksandid ja nende valmistamine EE04113B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers
PCT/EP1998/001651 WO1998042674A1 (en) 1997-03-25 1998-03-23 Substituted isoquinolines as ultra short acting neuromuscular blockers

Publications (2)

Publication Number Publication Date
EE9900424A EE9900424A (et) 2000-04-17
EE04113B1 true EE04113B1 (et) 2003-08-15

Family

ID=26311255

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900424A EE04113B1 (et) 1997-03-25 1998-03-23 Asendatud isokinoliinid kui ülilühikese toimekestusega perifeersed müorelaksandid ja nende valmistamine

Country Status (37)

Country Link
US (2) US6187789B1 (ko)
EP (4) EP1380573B1 (ko)
JP (3) JP4112015B2 (ko)
KR (2) KR100578443B1 (ko)
CN (1) CN1203061C (ko)
AP (1) AP1797A (ko)
AR (1) AR012156A1 (ko)
AT (3) ATE254107T1 (ko)
AU (2) AU745382B2 (ko)
BR (1) BR9808422B1 (ko)
CA (1) CA2284802C (ko)
CO (1) CO4940499A1 (ko)
CZ (1) CZ293786B6 (ko)
DE (3) DE69819703T2 (ko)
DK (2) DK0975599T3 (ko)
EA (1) EA002224B1 (ko)
EE (1) EE04113B1 (ko)
ES (2) ES2242275T3 (ko)
HK (1) HK1023342A1 (ko)
HR (1) HRP980157B1 (ko)
HU (1) HU228230B1 (ko)
ID (1) ID22901A (ko)
IL (1) IL131918A (ko)
IS (2) IS2346B (ko)
MA (1) MA26476A1 (ko)
MY (1) MY121316A (ko)
NO (1) NO314726B1 (ko)
NZ (1) NZ337797A (ko)
PE (1) PE68399A1 (ko)
PL (1) PL190860B1 (ko)
PT (2) PT971898E (ko)
RS (1) RS49869B (ko)
SI (1) SI0975599T1 (ko)
TR (1) TR199902330T2 (ko)
TW (1) TW505635B (ko)
UY (1) UY24933A1 (ko)
WO (2) WO1998042675A1 (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE254107T1 (de) * 1997-03-25 2003-11-15 Avera Pharmaceuticals Inc Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
US6911455B2 (en) * 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
WO2005041960A2 (en) * 2003-10-28 2005-05-12 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
EP2125742A2 (en) * 2007-03-08 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
AU2008231470A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
AU2008243749B2 (en) 2007-05-01 2012-05-03 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
WO2008155752A1 (en) 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
EP2197848A1 (en) * 2007-10-29 2010-06-23 Chemagis Ltd. Novel r,r'-atracurium salts
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
WO2010107488A1 (en) * 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
WO2011022491A1 (en) 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
US9156826B2 (en) * 2012-06-29 2015-10-13 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成（r）-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
SE7808267L (sv) * 1977-08-01 1979-02-02 Massachusetts Gen Hospital Neuromuskulert blockeringsmedel
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
ATE254107T1 (de) * 1997-03-25 2003-11-15 Avera Pharmaceuticals Inc Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Also Published As

Publication number Publication date
EA002224B1 (ru) 2002-02-28
IL131918A (en) 2005-09-25
CO4940499A1 (es) 2000-07-24
DE69819703D1 (de) 2003-12-18
CA2284802C (en) 2009-06-16
JP4112016B2 (ja) 2008-07-02
KR100578443B1 (ko) 2006-05-11
NO314726B1 (no) 2003-05-12
CA2284802A1 (en) 1998-10-01
JP2002517168A (ja) 2002-06-11
EA199900756A1 (ru) 2000-08-28
PL335885A1 (en) 2000-05-22
DE69819703T2 (de) 2004-09-30
HUP0001556A2 (hu) 2001-04-28
IS5185A (is) 1999-09-17
EP0971898A1 (en) 2000-01-19
WO1998042674A1 (en) 1998-10-01
AU745382B2 (en) 2002-03-21
EP1380573A3 (en) 2004-01-21
ES2242275T3 (es) 2005-11-01
BR9808422A (pt) 2000-05-23
AR012156A1 (es) 2000-09-27
KR100554601B1 (ko) 2006-03-03
IS2346B (is) 2008-03-15
IL131918A0 (en) 2001-03-19
DK0971898T3 (da) 2005-09-05
IS8717A (is) 2008-03-03
CZ340499A3 (cs) 2000-04-12
DK0975599T3 (da) 2004-03-15
EP0971898B1 (en) 2005-05-11
TR199902330T2 (xx) 2000-02-21
EP1380573B1 (en) 2009-05-06
DE69840816D1 (de) 2009-06-18
ID22901A (id) 1999-12-16
AU6730598A (en) 1998-10-20
MY121316A (en) 2006-01-28
SI0975599T1 (en) 2004-04-30
HRP980157A2 (en) 1999-02-28
HRP980157B1 (en) 2004-10-31
CZ293786B6 (cs) 2004-07-14
DE69830157D1 (de) 2005-06-16
AP9901658A0 (en) 1999-09-30
EP1380573A2 (en) 2004-01-14
CN1257483A (zh) 2000-06-21
US6187789B1 (en) 2001-02-13
ATE254107T1 (de) 2003-11-15
AU7521098A (en) 1998-10-20
RS49869B (sr) 2008-08-07
PE68399A1 (es) 1999-07-23
KR20010005621A (ko) 2001-01-15
BR9808422B1 (pt) 2010-08-24
KR20050103984A (ko) 2005-11-01
ATE430734T1 (de) 2009-05-15
UY24933A1 (es) 2000-12-29
AP1797A (en) 2007-11-15
US6177445B1 (en) 2001-01-23
WO1998042675A1 (en) 1998-10-01
JP2008019272A (ja) 2008-01-31
EP0975599A1 (en) 2000-02-02
HUP0001556A3 (en) 2002-01-28
DE69830157T2 (de) 2006-05-11
YU48399A (sh) 2002-06-19
TW505635B (en) 2002-10-11
MA26476A1 (fr) 2004-12-20
PL190860B1 (pl) 2006-02-28
EP1526130A1 (en) 2005-04-27
HK1023342A1 (en) 2000-09-08
HU228230B1 (en) 2013-02-28
NZ337797A (en) 2001-03-30
ATE295351T1 (de) 2005-05-15
PT975599E (pt) 2004-03-31
NO994680L (no) 1999-11-24
EP0975599B1 (en) 2003-11-12
ES2210757T3 (es) 2004-07-01
EE9900424A (et) 2000-04-17
NO994680D0 (no) 1999-09-24
PT971898E (pt) 2005-07-29
CN1203061C (zh) 2005-05-25
JP2002503220A (ja) 2002-01-29
JP4112015B2 (ja) 2008-07-02

Similar Documents

Publication Publication Date Title
EE04113B1 (et) Asendatud isokinoliinid kui ülilühikese toimekestusega perifeersed müorelaksandid ja nende valmistamine
ZA989505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
HK1042084B (zh) 取代的苯並咪唑及其製備和用途
HK1015765A1 (en) Dithiolan derivatives, their preparation and their therapeutic effect
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
ATE194598T1 (de) In der therapie verwendbare chinolin- und chinazolinverbindungen
ZA982478B (en) Compounds their use and preparation
HUP0000496A3 (en) Heterocyclically substituted benzamides and their use in fighting diseases
EE200000094A (et) Uued plokk-kopolümeerid ja nende saamine
SI0989121T1 (sl) Substituirani benzamidi in njihova uporaba kot imunomodulatorji
PL329308A1 (en) Derivatives of aminoisoquinoline and aminothienepyridine as well as their application as antinflammatory agents
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
ZA989556B (en) Benzoxazine derivatives their preparation and their therapeutic application
IL131756A0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NZ332757A (en) Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents
HUP0002961A3 (en) Synergistic fungicidal mixture and their use
ZA985253B (en) Quinolines and their therapeutic use
ZA982362B (en) Quinolin-2-(1h)-one and dihydroquinolin-2-(1h)-one derivatives their preparation and their therapeutic application
DE69811165T2 (de) Heparin-spezifische Glucanase-enthaltende Additivzubereitung und seine Verwendung
HK1020944A1 (en) Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds
IL136382A0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
IL120970A0 (en) N-acetonylbenzamides their preparation and their use as fungicides

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110323